Document 0049 DOCN M95B0049 TI Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. DT 9511 AU Ward GA; Stover CK; Moss B; Fuerst TR; MedImmune, Inc., Gaithersburg, MD 20878, USA. SO Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6773-7. Unique Identifier : AIDSLINE MED/95350151 AB We developed a stringently regulated expression system for mammalian cells that uses (i) the RNA polymerase, phi 10 promoter, and T phi transcriptional terminator of bacteriophage T7; (ii) the lac repressor, lac operator, rho-independent transcriptional terminators and the gpt gene of Escherichia coli; (iii) the RNA translational enhancer of encephalomyocarditis virus; and (iv) the genetic background of vaccinia virus. In cells infected with the recombinant vaccinia virus, reporter beta-galactosidase synthesis was not detected in the absence of inducer. An induction of at least 10,000- to 20,000-fold occurred upon addition of isopropyl beta-D-thiogalactopyranoside or by temperature elevation from 30 to 37 degrees C using a temperature-sensitive lac repressor. Regulated synthesis of the secreted and highly glycosylated human immunodeficiency virus 1 envelope protein gp120 was also demonstrated. Yields of both proteins were approximately 2 mg per 10(8) cells in 24 hr. Plasmid transfer vectors for cloning and expression of complete or incomplete open reading frames in recombinant vaccinia viruses are described. DE beta-Galactosidase/BIOSYNTHESIS/GENETICS Animal Base Sequence Cells, Cultured Cloning, Molecular/*METHODS Enzyme Induction *Gene Expression Regulation Genetic Vectors/*GENETICS Heat HIV Envelope Protein gp120/BIOSYNTHESIS/GENETICS Isopropyl Thiogalactoside/PHARMACOLOGY Molecular Sequence Data Recombinant Proteins/BIOSYNTHESIS Regulatory Sequences, Nucleic Acid/GENETICS Support, U.S. Gov't, P.H.S. Vaccinia Virus/*GENETICS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).